The purpose of this study is to learn about the safety and effectiveness of an investigational drug called Guselkumab in the treatment of ulcerative colitis. Guselkumab has already been approved by the TGA for the treatment of other inflammatory conditions, and this study aims to learn if it is effective in the treatment of ulcerative colitis as well.
Exclusions
March 2023 to March 2024
When Monique Perry was diagnosed with aggressive triple-negative breast cancer she feared her family history was about to repeat itself.
Mater researchers in Brisbane are leading a trial of a game-changing flu vaccine that has the potential to provide greater and more durable protection against the virus.
Stephanie Guilas has worked in many departments throughout Mater Hospital Brisbane, however, after 28 years of service, she found her true passion working within Mater Research’s Mothers and Babies...